183 related articles for article (PubMed ID: 7335401)
1. Management of the adolescent girl exposed in utero to DES.
Gerbie MV
Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
[TBL] [Abstract][Full Text] [Related]
2. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
Barclay DL
J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
[TBL] [Abstract][Full Text] [Related]
3. Development of DES-associated clear-cell carcinoma: the importance of regular screening.
Anderson B; Watring WG; Edinger DD; Small EC; Netland AT; Safaii H
Obstet Gynecol; 1979 Mar; 53(3):293-9. PubMed ID: 424100
[TBL] [Abstract][Full Text] [Related]
4. In utero exposure to DES. Evaluation and followup of 199 women.
Fowler WC; Edelman DA
Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
[TBL] [Abstract][Full Text] [Related]
5. Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. The clinical consequences of stilbestrol exposure in utero.
Kurman RJ
West J Med; 1979 Dec; 131(6):526-32. PubMed ID: 545869
[TBL] [Abstract][Full Text] [Related]
6. Squamous cell carcinoma in situ of the vagina and cervix after intrauterine DES exposure.
Veridiano NP; Tancer ML; Weiner EA
Obstet Gynecol; 1978 Jul; 52(1 Suppl):30S-33S. PubMed ID: 683639
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of the genital tract following stilbestrol exposure in utero.
Kurman RJ
Recent Results Cancer Res; 1979; 66():161-74. PubMed ID: 373028
[TBL] [Abstract][Full Text] [Related]
8. Six years' experience with screening of a diethylstilbestrol-exposed population.
Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
[TBL] [Abstract][Full Text] [Related]
9. Prenatal diethylstilbestrol exposure and human genital tract abnormalities.
Herbst AL; Scully RE; Robboy SJ
Natl Cancer Inst Monogr; 1979 May; (51):25-35. PubMed ID: 481577
[TBL] [Abstract][Full Text] [Related]
10. Natural history of vaginal adenosis in women exposed to diethylstilbestrol in utero.
Ng AB; Reagan JW; Nadji M; Greening S
J Reprod Med; 1977 Jan; 18(1):1-13. PubMed ID: 833795
[No Abstract] [Full Text] [Related]
11. Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions.
Robboy SJ; Scully RE; Welch WR; Herbst AL
Arch Pathol Lab Med; 1977 Jan; 101(1):1-5. PubMed ID: 576195
[TBL] [Abstract][Full Text] [Related]
12. Microglandular hyperplasia in vaginal adenosis associated with oral contraceptives and prenatal diethylstilbestrol exposure.
Robboy SJ; Welch WR
Obstet Gynecol; 1977 Apr; 49(4):430-4. PubMed ID: 857207
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum cathepsin B1 and vaginal pathology after prenatal DES exposure.
Pietras RJ; Szego CM; Mangan CE; Seeler BJ; Burtnett MM; Orevi M
Obstet Gynecol; 1978 Sep; 52(3):321-7. PubMed ID: 703988
[TBL] [Abstract][Full Text] [Related]
14. Comparison of histologic and colposcopic findings in DES-exposed females.
Welch WR; Robboy SJ; Townsend DE; Barnes AB; Scully RE; Herbst AL
Obstet Gynecol; 1978 Oct; 52(4):457-61. PubMed ID: 714329
[TBL] [Abstract][Full Text] [Related]
15. Vaginal epithelial changes in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project.
O'Brien PC; Noller KL; Robboy SJ; Barnes AB; Kaufman RH; Tilley BC; Townsend DE
Obstet Gynecol; 1979 Mar; 53(3):300-8. PubMed ID: 424101
[TBL] [Abstract][Full Text] [Related]
16. Induction of urogenital neoplasia and abnormalities from prenatal exposure to diethylstilbestrol.
Netzloff ML
Ann Clin Lab Sci; 1979; 9(4):263-7. PubMed ID: 485089
[TBL] [Abstract][Full Text] [Related]
17. Vaginal and cervical squamous cell dysplasia in women exposed to diethylstilbestrol in utero.
Burke L; Antonioli D; Rosen S
Am J Obstet Gynecol; 1978 Nov; 132(5):537-44. PubMed ID: 717453
[TBL] [Abstract][Full Text] [Related]
18. Physician advisory: health effects of the pregnancy use of diethylstilbestrol.
Richmond JB
Clin Toxicol; 1979 Mar; 14(3):313-8. PubMed ID: 37020
[TBL] [Abstract][Full Text] [Related]
19. Developmental mechanism of estrogen-induced irreversible changes in the mouse cervicovaginal epithelium.
Forsberg JG
Natl Cancer Inst Monogr; 1979 May; (51):41-56. PubMed ID: 384264
[TBL] [Abstract][Full Text] [Related]
20. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.
Herbst AL; Cole P; Colton T; Robboy SJ; Scully RE
Am J Obstet Gynecol; 1977 May; 128(1):43-50. PubMed ID: 851158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
